ClearArc Capital’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $255K | Sell |
2,361
-1,021
| -30% | -$110K | 0.1% | 240 |
|
|
2019
Q3 | $331K | Buy |
3,382
+53
| +2% | +$5.19K | 0.1% | 245 |
|
|
2019
Q2 | $436K | Sell |
3,329
-400
| -11% | -$52.4K | 0.13% | 190 |
|
|
2019
Q1 | $504K | Sell |
3,729
-100
| -3% | -$13.5K | 0.14% | 180 |
|
|
2018
Q4 | $373K | Sell |
3,829
-1,924
| -33% | -$187K | 0.11% | 211 |
|
|
2018
Q3 | $800K | Buy |
5,753
+79
| +1% | +$11K | 0.1% | 193 |
|
|
2018
Q2 | $704K | Sell |
5,674
-6
| -0.1% | -$744 | 0.1% | 203 |
|
|
2018
Q1 | $633K | Sell |
5,680
-24
| -0.4% | -$2.68K | 0.1% | 220 |
|
|
2017
Q4 | $682K | Sell |
5,704
-17
| -0.3% | -$2.03K | 0.09% | 216 |
|
|
2017
Q3 | $803K | Buy |
5,721
+201
| +4% | +$28.2K | 0.12% | 183 |
|
|
2017
Q2 | $672K | Buy |
5,520
+25
| +0.5% | +$3.04K | 0.11% | 200 |
|
|
2017
Q1 | $666K | Buy |
5,495
+53
| +1% | +$6.42K | 0.11% | 196 |
|
|
2016
Q4 | $666K | Sell |
5,442
-61
| -1% | -$7.47K | 0.12% | 187 |
|
|
2016
Q3 | $674K | Buy |
5,503
+75
| +1% | +$9.19K | 0.13% | 182 |
|
|
2016
Q2 | $634K | Sell |
5,428
-77
| -1% | -$8.99K | 0.12% | 187 |
|
|
2016
Q1 | $766K | Sell |
5,505
-7
| -0.1% | -$974 | 0.16% | 155 |
|
|
2015
Q4 | $1.05M | Buy |
5,512
+18
| +0.3% | +$3.43K | 0.22% | 123 |
|
|
2015
Q3 | $859K | Sell |
5,494
-49
| -0.9% | -$7.66K | 0.18% | 156 |
|
|
2015
Q2 | $1M | Buy |
5,543
+1,173
| +27% | +$212K | 0.18% | 146 |
|
|
2015
Q1 | $757K | Buy |
4,370
+125
| +3% | +$21.7K | 0.16% | 172 |
|
|
2014
Q4 | $785K | Buy |
4,245
+147
| +4% | +$27.2K | 0.16% | 170 |
|
|
2014
Q3 | $680K | Buy |
4,098
+110
| +3% | +$18.3K | 0.15% | 175 |
|
|
2014
Q2 | $623K | Buy |
3,988
+71
| +2% | +$11.1K | 0.14% | 186 |
|
|
2014
Q1 | $596K | Buy |
3,917
+23
| +0.6% | +$3.5K | 0.15% | 183 |
|
|
2013
Q4 | $517K | Buy |
3,894
+123
| +3% | +$16.3K | 0.13% | 190 |
|
|
2013
Q3 | $438K | Buy |
3,771
+30
| +0.8% | +$3.48K | 0.12% | 199 |
|
|
2013
Q2 | $345K | Buy |
+3,741
| New | +$345K | 0.09% | 241 |
|